TELA Bio, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
TELA Bio, Inc. (TELA) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$180.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-11
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $1.32M, a 5.45% decline year-over-year.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.50M.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $663.00K.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $633.00K, a 61.87% decline year-over-year.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $1.76M.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$1.81M, a 143.31% decline from fiscal 2023.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $4.18M, a 74.11% increase from fiscal 2022.
- TELA Bio, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $2.40M, a 10.25% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$180.00K 10-Q · filed 2026-08-11 | $483.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.12M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$1.50M 10-Q · filed 2026-05-13 | -$835.00K derived: sum of 2 quarters · filed 2026-05-13 | -$202.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.19M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.30M derived: sum of 2 quarters · filed 2026-03-25 | $2.69M derived: sum of 3 quarters · filed 2026-08-11 | $1.76M 10-K · filed 2026-03-25 |
| 2025-09-30 | $633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.03M derived: sum of 2 quarters · filed 2026-08-11 | $1.10M 10-Q · filed 2025-11-14 | $255.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $464.00K 10-Q · filed 2026-08-11 | -$378.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.28M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$930.00K 10-Q · filed 2026-05-13 | -$1.77M derived: sum of 2 quarters · filed 2026-05-13 | -$112.00K derived: sum of 3 quarters · filed 2026-05-13 | $735.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$842.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $818.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.67M derived: sum of 3 quarters · filed 2026-03-25 | -$1.81M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.51M derived: sum of 2 quarters · filed 2025-11-14 | -$967.00K 10-Q · filed 2025-11-14 | $1.84M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$2.63M 10-Q · filed 2025-08-11 | $177.00K derived: sum of 3 quarters · filed 2026-03-25 | $1.65M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | -$3.47M 10-Q · filed 2025-05-08 | -$670.00K derived: sum of 2 quarters · filed 2026-03-25 | $807.00K derived: sum of 3 quarters · filed 2026-03-25 | $2.39M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.28M derived: sum of 2 quarters · filed 2026-03-25 | $5.87M derived: sum of 3 quarters · filed 2026-03-25 | $4.18M 10-K · filed 2026-03-25 |
| 2023-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $3.06M derived: sum of 2 quarters · filed 2024-11-08 | $1.37M 10-Q · filed 2024-11-08 | $2.97M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$104.00K 10-Q · filed 2024-08-13 | $1.50M derived: sum of 3 quarters · filed 2025-03-21 | $2.08M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | -$1.69M 10-Q · filed 2024-05-10 | -$91.00K derived: sum of 2 quarters · filed 2025-03-21 | $492.00K derived: sum of 3 quarters · filed 2025-03-21 | $2.63M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $2.18M derived: sum of 2 quarters · filed 2025-03-21 | $4.32M derived: sum of 3 quarters · filed 2025-03-21 | $2.40M 10-K · filed 2025-03-21 |
| 2022-09-30 | $583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.72M derived: sum of 2 quarters · filed 2023-11-13 | $799.00K 10-Q · filed 2023-11-13 | $1.91M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $216.00K 10-Q · filed 2023-08-10 | $1.33M derived: sum of 3 quarters · filed 2024-03-22 | $2.35M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | -$1.92M 10-Q · filed 2023-05-11 | -$808.00K derived: sum of 2 quarters · filed 2024-03-22 | $215.00K derived: sum of 3 quarters · filed 2024-03-22 | $1.95M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.13M derived: sum of 2 quarters · filed 2024-03-22 | $3.87M derived: sum of 3 quarters · filed 2024-03-22 | $2.67M 10-K · filed 2024-03-22 |
| 2021-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.75M derived: sum of 2 quarters · filed 2022-11-10 | $1.56M 10-Q · filed 2022-11-10 | $3.05M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $538.00K 10-Q · filed 2022-08-11 | $2.03M derived: sum of 3 quarters · filed 2023-03-23 | $3.72M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | -$1.19M 10-Q · filed 2022-05-11 | $297.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.99M derived: sum of 3 quarters · filed 2023-03-23 | $1.82M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $3.18M derived: sum of 2 quarters · filed 2023-03-23 | $3.01M derived: sum of 3 quarters · filed 2023-03-23 | $2.32M 10-K · filed 2023-03-23 |
| 2020-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.52M derived: sum of 2 quarters · filed 2021-11-12 | $831.00K 10-Q · filed 2021-11-12 | $757.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$859.00K 10-Q · filed 2021-08-12 | -$933.00K derived: sum of 3 quarters · filed 2022-03-23 | -$854.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | -$692.00K 10-Q · filed 2021-05-14 | -$766.00K derived: sum of 2 quarters · filed 2022-03-23 | -$687.00K derived: sum of 3 quarters · filed 2022-03-23 | -$256.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $5.00K derived: sum of 2 quarters · filed 2022-03-23 | $436.00K derived: sum of 3 quarters · filed 2022-03-23 | -$118.00K 10-K · filed 2022-03-23 |
| 2019-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $510.00K derived: sum of 2 quarters · filed 2020-11-12 | -$44.00K 10-Q · filed 2020-11-12 | $303.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$123.00K 10-Q · filed 2020-08-13 | $224.00K derived: sum of 3 quarters · filed 2021-03-25 | |
| 2019-03-31 | -$554.00K 10-Q · filed 2020-05-15 | -$207.00K derived: sum of 2 quarters · filed 2021-03-25 | ||
| 2018-12-31 | $347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$1.19M 10-K · filed 2021-03-25 | ||
| 2018-09-30 | -$1.54M 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | $1.59M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |